Bipinesh Sansar
@Bipinesh
Followers
171
Following
158
Statuses
203
MD, DM Medical Oncology Interests - #SelfcareforDoctors #Gerionc #IntegrativeOncology #medoncovns #Gynaeonco #Sarcoma #Rarecancers #Supportivecareinoncology
Joined December 2009
RT @drakhilkapoor1: Lung Cancer Awareness Program held today at Tata Memorial Centre, Varanasi with 250+ patients and caregivers. Every st…
0
8
0
RT @BikrantLal: Proud to present our latest guidelines: Diagnosis and management of pediatric acute liver failure: consensus recommendation…
0
3
0
RT @the_nuclear_doc: Perhaps the first Triveoctin PET of India @TMC_Varanasi Case of GBM IDH wild type Triveoctin targets αvβ8-Integrin…
0
6
0
RT @the_nuclear_doc: Perhaps the First PDL1 PET/CT of India PDL1 PET/CT is a non invasive investigation which gives a novel insight into t…
0
6
0
RT @CRSTonline: Dr. Neha Singh and team present an audit of liver metastatic tumors, highlighting adenocarcinomas often originating from th…
0
3
0
@Erman_Akkus @CancerCareMASCC @JCOOP_ASCO How much time before paclitaxel infusion was cetrizine given?
1
0
0
RT @drakhilkapoor1: Results of our Phase III RCT of addition of Triple OMCT to Chemotherapy in platinum sensitive HNSCC. Both significant…
0
21
0
RT @OncMedEdCoP: Join the MedEd CoP #ASCO24 session IN ONE HOUR! Find us in S103, 7:30-9:30 AM! #MedEd #Oncology #OncMedEd #ASCOMedEdCoP…
0
6
0
RT @doclauravater: A physician who cares about their wellbeing is not "uncommitted" to medicine. They've seen doctors leave the field (and…
0
78
0
RT @drakhilkapoor1: Alterations in p53, RB1, TP53 are important to be identified in mCRPC. Dictates the addition of Carboplatin in the "AVP…
0
3
0
RT @drakhilkapoor1: Thrilled to inform that our research project MICROBIOME in LUNG CANCER has received international grant of 50000 USD a…
0
10
0
RT @drakhilkapoor1: A video on youtube as a part of my interview on importance of Clinical Trials. Can be useful to motivate patients and l…
0
5
0
RT @drakhilkapoor1: Importance of Geriatric Oncology and highlights of problems in Indian scenario A lot more to do, this is just a beginn…
0
5
0
RT @drakhilkapoor1: A very interesting debate was conducted at the Uro-Oncology Conference at TMH, Varanasi. Gem-Cis-Nivo versus Gem-platin…
0
8
0
A session at our two day " Grey areas in Uro-oncology" meet starting today at HBCH and MPMMCC, Varanasi
2
0
19
RT @drakhilkapoor1: Median OS in OMCT Study was 9 months with Triple OMCT vs. 5 months with Physician Choice therapy. Cost of therapy: Hard…
0
2
0
RT @drakhilkapoor1: Results of Our Triple OMCT in platinum resistant settings in advanced Head Neck Cancers presented at ESMO 2023. Median…
0
11
0
Adenoid Cystic carcinoma - Variable course but quite often indolent Good response to initial chemotherapy High disease control rates with TKIs like lenvatinib in second line and beyond MASC - Very high chance of NTRK fusions
0
0
2